Sci-Tech Portal St. Lucia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Portal St. Lucia.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on December 18, 2025

Dec. 18, 2025

Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia

GlobeNewswire

Dec. 18, 2025

Senti Biosciences Announces New Employment Inducement Grants

GlobeNewswire

Dec. 18, 2025

Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients

GlobeNewswire

Dec. 18, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 18, 2025

Crescent Biopharma Announces Grants of Inducement Awards

GlobeNewswire

Dec. 18, 2025

Abivax to be Added to Nasdaq Biotechnology Index

GlobeNewswire

Dec. 18, 2025

vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health

GlobeNewswire

Dec. 18, 2025

Crinetics Pharmaceuticals to Participate in The 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Dec. 18, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Dec. 18, 2025

Cartesian Therapeutics Announces the Appointment of Adrian Bot to Board of Directors

GlobeNewswire

Dec. 18, 2025

Cue Biopharma Announces Proposed Public Offering

GlobeNewswire

Dec. 18, 2025

Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus

GlobeNewswire

Dec. 18, 2025

Galapagos maakt topline resultaten bekend van twee fase 3-enabling studies met selectieve TYK2-remmer GLPG3667 bij dermatomyositis en systemische lupus erythematodes

GlobeNewswire

Dec. 18, 2025

DVCon U.S. 2026 Announces Keynote Speakers, Tutorials and Workshops

GlobeNewswire

Dec. 18, 2025

Verano Founder and Chief Executive Officer George Archos Shares Celebratory Comments on Cannabis Rescheduling Announcement

GlobeNewswire

Dec. 18, 2025

Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth

GlobeNewswire

Dec. 18, 2025

AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share

GlobeNewswire

Dec. 18, 2025

TSplus Academy Strengthens Its eLearning Platform with New Resources to Empower Remote Access Users

GlobeNewswire

Dec. 18, 2025

Integer Holdings Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Integer Holdings Corporation - ITGR

GlobeNewswire

Dec. 18, 2025

DeFi Technologies Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against DeFi Technologies Inc. - DEFT

GlobeNewswire